CDKN2A and cancer: Deletion or inactivating mutations in the p16 gene are observed in many human cancers.6, 7 The catalytic activity of Cdk4 depends on its activation by the protein cyclin D1, which is expressed during the G0/G1 phase of the cell cycle.